Treatment with Cyclic AMP Activators Reduces Glioblastoma Growth and Invasion as Assessed by Two-Photon Microscopy
Open Access
- 4 March 2021
- Vol. 10 (3), 556
- https://doi.org/10.3390/cells10030556
Abstract
(1) Background: Despite progress in surgery and radio-chemotherapy of glioblastoma (GB), the prognosis remains very poor. GB cells exhibit a preference for hypoxia to maintain their tumor-forming capacity. Enhancing oxidative phosphorylation—known as the anti-Warburg effect—with cyclic AMP activators has been demonstrated to drive GB cells from proliferation to differentiation thereby reducing tumor growth in a cell culture approach. Here we re-evaluate this treatment in a more clinically relevant model. (2) Methods: The effect of treatment with dibutyryl cyclic AMP (dbcAMP, 1 mM) and the cAMP activator forskolin (50µM) was assessed in a GB cell line (U87GFP+, 104 cells) co-cultured with mouse organotypic brain slices providing architecture and biochemical properties of normal brain tissue. Cell viability was determined by propidium-iodide, and gross metabolic effects were excluded in the extracellular medium. Tumor growth was quantified in terms of area, volume, and invasion at the start of culture, 48 h, 7 days, and 14 days after treatment. (3) Results: The tumor area was significantly reduced following dbcAMP or forskolin treatment (F2,249 = 5.968, p = 0.0029). 3D volumetric quantification utilizing two-photon fluorescence microscopy revealed that the treated tumors maintained a spheric shape while the untreated controls exhibited the GB typical invasive growth pattern. (4) Conclusions: Our data demonstrate that treatment with a cAMP analog/activator reduces GB growth and invasion.Keywords
This publication has 43 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Scale to Predict Survival After Surgery for Recurrent Glioblastoma MultiformeJournal of Clinical Oncology, 2010
- Cyclic AMP Suppression Is Sufficient to Induce Gliomagenesis in a Mouse Model of Neurofibromatosis-1Cancer Research, 2010
- U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell LinePLoS Genetics, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Acute Plasmalemma Permeability and Protracted Clearance of Injured Cells after Controlled Cortical Impact in MiceJournal of Cerebral Blood Flow & Metabolism, 2007
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- Quantitative Analysis of Glioma Cell Invasion by Confocal Laser Scanning Microscopy in a Novel Brain Slice ModelBiochemical and Biophysical Research Communications, 2000